Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

JJ Failing, Y Yan, LF Porrata, SN Markovic - Melanoma Research, 2017 - journals.lww.com
The peripheral blood lymphocyte-to-monocyte ratio (LMR) has been associated with
prognosis in many malignancies including metastatic melanoma. However, it has not been …
被引用次数：41 相关文章

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

JJ Failing, Y Yan, LF Porrata… - Melanoma …, 2017 - pubmed.ncbi.nlm.nih.gov
The peripheral blood lymphocyte-to-monocyte ratio (LMR) has been associated with
prognosis in many malignancies including metastatic melanoma. However, it has not been …

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

JJ Failing, Y Yan, LF Porrata… - Melanoma …, 2017 - mayoclinic.elsevierpure.com
The peripheral blood lymphocyte-to-monocyte ratio (LMR) has been associated with
prognosis in many malignancies including metastatic melanoma. However, it has not been …

[引用][C] Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

JJ Failing, Y Yan, LF Porrata, SN Markovic - Melanoma Research, 2017 - cir.nii.ac.jp
Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic
melanoma patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients.

JJ Failing, Y Yan, LF Porrata, SN Markovic - Melanoma Research, 2017 - europepmc.org
The peripheral blood lymphocyte-to-monocyte ratio (LMR) has been associated with
prognosis in many malignancies including metastatic melanoma. However, it has not been …

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients

JJ Failing, Y Yan, LF Porrata… - Melanoma Research, 2017 - ingentaconnect.com
The peripheral blood lymphocyte-to-monocyte ratio (LMR) has been associated with
prognosis in many malignancies including metastatic melanoma. However, it has not been …